Reference Product Substitution

Reference Product Substitution is a regulatory and methodological framework within pharmaceutical policy that identifies a designated approved drug product used as the basis for evaluating the therapeutic equivalence of generic or follow-on drugs in lieu of an original reference listed drug.

18

Publications

568

Citations

143

Authors

66

Institutions

Publications per year

2017–2026

9

Authors

143

  1. JD
    Jeremiah D. Momper

    University of California San Diego, United States

    1 publications · 77 citations

    1

    h-index

  2. TN
    T. N. Walsh

    Connolly Hospital Blanchardstown, Ireland

    1 publications · 28 citations

    1

    h-index

  3. IC
    Inês Cordeiro

    Hospitais da Universidade de Coimbra, Portugal

    1 publications · 29 citations

    1

    h-index

  4. GP
    Giuseppina Paola Parpinello

    University of Bologna, Italy

    1 publications · 45 citations

    1

    h-index

  5. RA
    Rui André

    University of Lisbon, Portugal

    1 publications · 29 citations

    1

    h-index

1–5 of 143

Venues

  1. Journal of Managed Care & Specialty Pharmacy

    JMCP · 2 publications · 41 citations

    2

    h-index

  2. Revista Española de Enfermedades Digestivas

    1 publications · 18 citations

    1

    h-index

  3. Open Access Rheumatology Research and Reviews

    1 publications · 28 citations

    1

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 13 citations

    1

    h-index

  5. Generics and Biosimilars Initiative Journal

    1 publications · 30 citations

    1

    h-index

1–5